Clinical Trial: Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase IV,Open Label Study of the Treatment of Children With Moderate to Severe Atopic Dermatitis (AD) Using Locobase® REPAIR as an Adjunctive to Standard Treatment

Brief Summary: To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD

Detailed Summary:
Sponsor: Astellas Pharma Europe B.V.

Current Primary Outcome: Change in mEASI from baseline to week 3 [ Time Frame: 3 Weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Physicians Global Evaluation of Clinical Response [ Time Frame: 6 Weeks ]

Original Secondary Outcome: Same as current

Information By: Astellas Pharma Inc

Dates:
Date Received: May 6, 2008
Date Started: March 2008
Date Completion:
Last Updated: August 22, 2014
Last Verified: August 2014